SANUWAVE Health (SNWV) Liabilities and Shareholders Equity (2010 - 2026)
SANUWAVE Health's (SNWV) quarterly Liabilities and Shareholders Equity came in at $37.1 million in Q1 2026, up 20.23% year-on-year from $30.9 million in Q1 2025, and down 0.66% on a QoQ basis from $37.3 million in Q4 2025.
SANUWAVE Health (SNWV) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends
SANUWAVE Health (SNWV) has 17 years of Liabilities and Shareholders Equity data on file, last reported at $37.1 million in Q1 2026.
- On a quarterly basis, Liabilities and Shareholders Equity rose 20.23% year-over-year to $37.1 million in Q1 2026; TTM through Mar 2026 was $143.1 million, a 37.81% increase from a year earlier, with the FY2025 full-year figure at $37.3 million, up 23.98% from the prior year.
- Liabilities and Shareholders Equity for Q1 2026 stood at $37.1 million, down from $37.3 million in the prior quarter.
- Over the last five years, Liabilities and Shareholders Equity for SNWV reached as high as $37.3 million in Q4 2025 and fell as low as $17.0 million in Q1 2022.
- Historically, Liabilities and Shareholders Equity has averaged $24.9 million across 5 years, with a median of $21.8 million in 2024.
- Across the five-year window, Liabilities and Shareholders Equity dropped 16.1% in 2022 and surged 62.97% in 2025, its largest moves.
- Year by year, Liabilities and Shareholders Equity stood at $19.9 million in 2022, then increased by 12.8% to $22.4 million in 2023, then soared by 34.36% to $30.1 million in 2024, then advanced by 23.98% to $37.3 million in 2025, then dropped by 0.66% to $37.1 million in 2026.
- Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $37.1 million in Q1 2026, $37.3 million in Q4 2025, and $35.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 6.63 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 31.92 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 10.46 Bn |
| 10 | SANUWAVE Health | 18.65 Mn | 7.87 Mn | 7.43 Mn | 37.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 37.10 Mn |
| Dec 31, 2025 | 37.34 Mn |
| Sep 30, 2025 | 35.60 Mn |
| Jun 30, 2025 | 33.05 Mn |
| Mar 31, 2025 | 30.86 Mn |
| Dec 31, 2024 | 30.12 Mn |
| Sep 30, 2024 | 21.84 Mn |
| Jun 30, 2024 | 21.01 Mn |
| Mar 31, 2024 | 23.32 Mn |
| Dec 31, 2023 | 22.42 Mn |
| Sep 30, 2023 | 20.34 Mn |
| Jun 30, 2023 | 19.20 Mn |
| Mar 31, 2023 | 17.50 Mn |
| Dec 31, 2022 | 19.87 Mn |
| Sep 30, 2022 | 18.78 Mn |
| Jun 30, 2022 | 17.84 Mn |
| Mar 31, 2022 | 17.01 Mn |
| Dec 31, 2021 | 18.62 Mn |
| Sep 30, 2021 | 19.18 Mn |
| Jun 30, 2021 | 19.74 Mn |